Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic reviewArticle Published on 2022-11-012022-11-16 Journal: Annals of Clinical and Translational Neurology [Category] 변종, [키워드] ACE affected Analysis association chemokine cohort study components conditions COVID-19 cytokine signaling Enzymes evolutionary relationship expression fatigue functional annotation Genetic genetic component Genetic variant highlight HLA-A HLA-C HLA-DQA1 HLA-DRB1 immune dysfunction Inflammation investigated Mental Ontology Pathogenesis Pathway analysis Pathways performed physical Protein Proteins receptor signaling significantly similarity Symptoms syndrome systematic review T cell activation TYK2 [DOI] 10.1002/acn3.51631 PMC 바로가기
Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivorsArticle Published on 2022-11-012022-11-15 Journal: Pain [Category] COVID19(2023년), SARS, 바이오마커, [키워드] Analysis analyzed association Biomarker Clinical data cohort study collected collecting data Comorbidities conducted coronavirus disease COVID-19 COVID-19 severity discharge exhibited Factors First wave Glucose greater hospital Hospital admission hospital discharge hospitalised Hospitalized hospitalized COVID-19 Inflammatory biomarker investigated Lymphocyte count Other outbreak Pain participant Patient Predictive Prevalence serological severity significantly Spain survivor Survivors Symptom Symptoms were assessed with COVID-19 women [DOI] 10.1097/j.pain.0000000000002608 PMC 바로가기
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort StudyArticle Published on 2022-10-312023-07-10 Journal: Viruses [Category] COVID19(2023년), [키워드] antibody waning cohort study COVID-19 electrochemiluminescence assay fixed-effect models SARS-CoV-2 seroreactivity [DOI] 10.3390/v14112416 PMC 바로가기
Bamlanivimab Use in a Military Treatment FacilityArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Administered administration Admission analyzed approval approved Arm bamlanivimab Care caused cohort study coronavirus coronavirus disease COVID-19 COVID-19 patient death declined diagnosed Disease progression facility FDA Follow-up Guidance help hospital Hospital admission Hospitalization information initial inpatient admission institutional review board intravenous IRB lack Mild-to-moderate monoclonal antibody Patient patients patients with SARS-CoV-2 placebo group Prevent Primary outcome progression provided receiving replicated reported required retrospective risk risk factor SARS-CoV-2 secondary outcome self-reported symptom severe COVID-19 small sample size Spread statistical significance statistically significant Study design Symptom treated Treatment treatment group virus-neutralizing was obtained were given Wuhan, China [DOI] 10.1093/milmed/usab188 PMC 바로가기
Association of Results of Four Lateral Flow Antibody Tests with Subsequent SARS-CoV-2 InfectionArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% confidence interval acute respiratory syndrome adjusted anti-SARS-CoV-2 IgG antibody assist association baseline Cohort cohort study conducted coronavirus Coverage COVID COVID-19 demonstrated disease risk England fire Flow Follow-up hospital IgG Immunity immunoassay immunoassays incidence rate individual Infection investigated Laboratory laboratory assays Lateral Lateral flow device lateral flow device. lateral flow immunoassay Lateral flow test LFIA LFIAs management microbiologically natural infection pandemic participant point-of-care test Poisson regression model Police service Population screening positive predicted prospective cohort study Protective Rapid Rapid test rapid test cassette recruitment Research Result risk risk factor Roche SARS-CoV-2 SARS-CoV-2 disease SARS-CoV-2 IgG SARS-COV-2 infection specificity subsequent Surescreen susceptibility symptomatic SARS-CoV-2 infection Test threshold United Kingdom unvaccinated populations Vaccine was tested [DOI] 10.1128/spectrum.02468-22 PMC 바로가기
Pre-vaccination RT-PCR negative contacts in workplace settings show high, SARS COV-2 neutralizing antibody levelsArticle Published on 2022-10-252022-11-15 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] age anti-SARS-CoV-2 antibody carried characterized Cohort cohort study collected Contact COVID-19 evaluated individual Infection infection control measure neutralization Neutralizing antibodies neutralizing antibody Outbreaks PCR PCR negative contacts positive Protective Ratio risk factor Risk factors RT-PCR SARS-CoV-2 SARS-COV-2 infection selected Seroprevalence significantly higher specific neutralizing antibody tested Transmission dynamics transmission of SARS-CoV-2 vaccination was tested while Workplace Workplace settings. [DOI] 10.1186/s12889-022-14381-5 PMC 바로가기
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research PartnershipArticle Published on 2022-10-062022-11-15 Journal: Vaccine [Category] 진단, [키워드] adjusted hazard ratio Administered Adults BNT162b2 clinical trial Cohort cohort study Community Community study confidence interval COVID-19 COVID-19 vaccine COVID-19 vaccines dose evaluated Evidence feasibility females first vaccination immunogenic Infection less male participant mRNA mRNA-1273 North not affect notable Older participant partnership point-of-care receiving Reporting SARS-CoV-2 SARS-CoV-2 serology second vaccination Seroconversion seroconversion rate seroconvert serology shown Symptom [DOI] 10.1016/j.vaccine.2022.09.021 PMC 바로가기
Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19Article Published on 2022-10-062022-11-15 Journal: PLoS ONE [Category] 바이오마커, [키워드] 95%CI Accuracy adjusted analyzed AOR association assumption Biomarker cohort study COVID-19 COVID-19 patient creatinine cut-off death disease severity elevated enrolled hospital hospitalized COVID-19 Infection IQR Limited males median age monitoring Mortality Neutrophil-to-lymphocyte ratio NLR non-survivor Odds ratio outcome Patient patients hospitalized point-of-care predict predictor Prognosis Prognostic marker progression Prospective receiver operating characteristics Sensitivity and specificity serum creatinine Severe case severity significantly significantly higher Still survivor the disease Treatment with COVID-19 [DOI] 10.1371/journal.pone.0275391 PMC 바로가기
Factors associated with complications from COVID-19 in hospital workers: A retrospective cohort studyArticle Published on 2022-10-042023-07-10 Journal: Medwave [Category] COVID19(2023년), [키워드] cohort study COVID-19 hospital workers. SARS-CoV-2 [DOI] 10.5867/medwave.2022.09.2536
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New EnglandArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] 30-Day mortality 95% CI accounted adjusted adjusted odds ratio Admission Admissions age Analysis appear applied approach assigned B.1.1.529 B.1.617.2 cohort study confirmed COVID-19 case confounders confounding factor COVID-19 Delta delta variant England estimate Factor Hospitalization infections intensive care intrinsic intrinsically invasive ventilation less Lineage Longitudinal data mass Mortality multicenter New occurred omicron outcome outcomes retrospective cohort study risk SARS-CoV-2 secondary severity significantly Vaccinations variant variants variety were excluded with COVID-19 women [DOI] 10.1001/jamanetworkopen.2022.38354 PMC 바로가기